Influence of high-dose estrogen exposure during adolescence on mammographic density for age in adulthood

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 121-129

  Jordan, Helen L ^a   Hopper, John L ^b   Thomson, Russell J ^a   Kavanagh, Anne M ^b   Gertig, Dorota M ^c   Stone, Jennifer ^b   Venn, Alison J ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIAN CYTOLOGY SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY MASS; BREAST; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COMPUTER; CONTROLLED STUDY; DENSITY; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; MEDICAL RECORD; PATIENT ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TELEPHONE;

ADOLESCENT; ADULT; BREAST; BREAST NEOPLASMS; DIETHYLSTILBESTROL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; MAMMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 74549224043     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0434     Document Type: Article

References (51)

1. Goldzieher MA. Treatment of excessive growth in the adolescent female. J Clin Endocrinol Metab 1956;16:249-52.
2. Ritzen EM, Nilsson O, Grigelioniene G, Holst M, Savendahl L, Wroblewski J. Estrogens and human growth. J Steroid Biochem Mol Biol 2000;74:383-6.
3. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
4. Barnard ND, Scialli AR, Bobela S. The current use of estrogens for growth-suppressant therapy in adolescent girls. J Pediatr Adolesc Gynecol 2002;15:23-6.
5. Jordan HL, Bruinsma FJ, Thomson RJ, Amir LH, Werther GA, Venn AJ. Adolescent exposure to high-dose estrogen and subsequent effects on lactation. Reprod Toxicol 2007;24:397-402.
6. Okasha M, McCarron P, Gunnell D, Smith GD. Exposures in childhood, adolescence and early adulthood and breast cancer risk: a systematic review of the literature. Breast Cancer Res Treat 2003; 78:223-76.
7. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995;4:567-71.
8. Drop SL, Greggio N, Cappa M, Bernasconi S. Current concepts in tall stature and overgrowth syndromes. J Pediatr Endocrinol Metab 2001;2:975-84.
9. Venn A, Bruinsma F, Werther G, et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet 2004;364:1513-8.
10. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
11. Stone J. Genetic and environmental determinants of mammographically dense and non-dense breast tissue: biomarkers for breast cancer [dissertation]. The University of Melbourne; 2007.
12. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7.
13. Colacurci N, Fornaro F, De Franciscis P, Mele D, Palermo M, del Vecchio W. Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001;76:451-5.
14. Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587-98.
15. Tanner JM. Growth at adolescence. Oxford: Blackwell Scientific Publications; 1962.
16. Greulich W, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press; 1959.
17. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc 1964;Series B 26:211-52.
18. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling [with discussion]. Appl Stat 1994;43:429-67.
19. Titus-Ernstoff L, Tosteson AN, Kasales C, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006;17:1281-90.
20. Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH. Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 2005;14:2634-40.
21. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol 2000; 29:629-36.
22. Butler LM, Gold EB, Greendale GA, et al. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat 2008; 112:165-74.
23. Dite GS, Gurrin LC, Byrnes GB, et al. Predictors of mammographic density: insights gained from a novel regression analysis of a twin study. Cancer Epidemiol Biomarkers Prev 2008;17:3474-81.
24. Rooman RP, De Beeck LO, Martin M, van Doorn J, Mohan S, Du Caju MV. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol 2005;152:597-604.
25. Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT. Insulinlike growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev 2007;16: 57-62.
26. dos Santos Silva I, Johnson N, De Stavola B, et al. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:449-55.
27. Diorio C, Pollak M, Byrne C, et al. Insulin-like growth factor-I, IGFbinding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1065-73.
28. Kleinberg DL, Feldman M, Ruan W. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 2000;5:7-17.
29. Juul A. The effects of oestrogens on linear bone growth. Hum Reprod Update 2001;7:303-13.
30. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogenprogestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997;15:3201-7.
31. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001;285:171-6.
32. Johansson H, Gandini S, Bonanni B, et al. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 2008;108:57-67.
33. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 2000; 9:15-24.
34. Velie EM, Nechuta S, Osuch JR. Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. Breast Dis 2005;24:17-35.
35. Forman MR, Cantwell MM, Ronckers C, Zhang Y. Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest 2005;23:609-24.
36. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 2007;8:1088-100.
37. Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR. Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer 2005;114:461-4.
38. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. Int J Gynecol Cancer 2006;16: 569-75.
39. Hilakivi-Clarke L, Forsen T, Eriksson JG, et al. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer 2001;85:1680-4.
40. De Stavola BL, dos Santos Silva I, McCormack V, Hardy RJ, Kuh DJ, Wadsworth ME. Childhood growth and breast cancer. Am J Epidemiol 2004;159:671-82.
41. Stoll BA. Teenage obesity in relation to breast cancer risk. Int J Obes Relat Metab Disord 1998;22:1035-40.
42. Berkey CS, Frazier AL, Gardner JD, Colditz GA. Adolescence and breast carcinoma risk. Cancer 1999;85:2400-9.
43. Herrinton LJ, Husson G. Relation of childhood height and later risk of breast cancer. Am J Epidemiol 2001;154:618-23.
44. Stavola BL, Hardy R, Kuh D, Silva IS, Wadsworth M, Swerdlow AJ. Birthweight, childhood growth and risk of breast cancer in a British cohort. Br J Cancer 2000;83:964-8.
45. Baer HJ, Rich-Edwards JW, Colditz GA, Hunter DJ, Willett WC, Michels KB. Adult height, age at attained height, and incidence of breast cancer in premenopausal women. Int J Cancer 2006;119: 2231-5.
46. Li CI, Malone KE, White E, Daling JR. Age when maximum height is reached as a risk factor for breast cancer among young U.S. women. Epidemiology 1997;8:559-65.
47. McCormack VA, dos Santos Silva I, De Stavola BL, et al. Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort. Br J Cancer 2003;89: 852-9.
48. Sellers TA, Vachon CM, Pankratz VS, et al. Association of childhood and adolescent anthropometric factors, physical activity, and diet with adult mammographic breast density. Am J Epidemiol 2007; 166:456-64.
49. Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM. Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1502-8.
50. Samimi G, Colditz GA, Baer HJ, Tamimi RM. Measures of energy balance and mammographic density in the Nurses' Health Study. Breast Cancer Res Treat 2008;109:113-22.
51. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.